Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Plant Mol Biol ; 100(6): 659-674, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31187392

RESUMEN

KEY MESSAGE: Oxalotrophic Stenotrophomonas isolated from tomato rhizosphere are able to protect plants against oxalate-producing pathogens by a combination of actions including induction of plant defence signalling callose deposition and the strengthening of plant cell walls and probably the degradation of oxalic acid. Oxalic acid plays a pivotal role in the virulence of the necrotrophic fungi Botrytis cinerea and Sclerotinia sclerotiorum. In this work, we isolated two oxalotrophic strains (OxA and OxB) belonging to the bacterial genus Stenotrophomonas from the rhizosphere of tomato plants. Both strains were capable to colonise endophytically Arabidopsis plants and protect them from the damage caused by high doses of oxalic acid. Furthermore, OxA and OxB protected Arabidopsis from S. sclerotiorum and B. cinerea infections. Bacterial inoculation induced the production of phenolic compounds and the expression of PR-1. Besides, both isolates exerted a protective effect against fungal pathogens in Arabidopsis mutants affected in the synthesis pathway of salicylic acid (sid2-2) and jasmonate perception (coi1). Callose deposition induced by OxA and OxB was required for protection against phytopathogens. Moreover, B. cinerea and S. sclerotiorum mycelial growth was reduced in culture media containing cell wall polysaccharides from leaves inoculated with each bacterial strain. These findings suggest that cell walls from Arabidopsis leaves colonised by these bacteria would be less susceptible to pathogen attack. Our results indicate that these oxalotrophic bacteria can protect plants against oxalate-producing pathogens by a combination of actions and show their potential for use as biological control agents against fungal diseases.


Asunto(s)
Hongos/patogenicidad , Oxalatos/metabolismo , Solanum lycopersicum/microbiología , Stenotrophomonas/fisiología , Arabidopsis/metabolismo , Botrytis/metabolismo , Botrytis/patogenicidad , Pared Celular/metabolismo , Ciclopentanos/química , Hongos/metabolismo , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Ácido Oxálico/metabolismo , Oxilipinas/química , Filogenia , Enfermedades de las Plantas/microbiología , Hojas de la Planta/metabolismo , Proteínas de Plantas/metabolismo , Polisacáridos/metabolismo , Ácido Salicílico/farmacología , Transducción de Señal , Stenotrophomonas/aislamiento & purificación
2.
J Microbiol Immunol Infect ; 57(1): 156-163, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37919171

RESUMEN

BACKGROUND: Proper identification of the polymicrobial microorganisms in patients with limb-threatening diabetic foot ulcers (LTDFUs) using conventional culture is insufficient. This prospective study evaluates the potential value of adjuvant molecular testing assisting in identify fastidious micro-organisms in LTDFUs compared to standard treatment alone. METHODS: Ninety patients with LTDFUs received interdisciplinary and standard antibiotic treatment in a referral diabetic foot center. A simultaneous 16S amplicon sequencing (16S AS) specimen along with conventional culture collected at admission was used to retrospectively evaluate the microbiological findings and its association with amputation outcomes. RESULTS: The microorganism count revealed by 16S AS overwhelmed that of conventional culturing (17 vs. 3 bacteria/ulcer respectively). The Stenotrophomonas spp. revealed in 29 patients were highly correlated with major (above ankle) amputation (OR: 4.76, 95% CI 1.01-22.56), while only one had been concomitantly identified by conventional culturing. Thus, there were 27 cases without proper antibiotics coverage during treatment. CONCLUSIONS: Adjuvant molecular testing assisted identification of fastidious pathogens such as Stenotrophomonas infection and might be associated with major amputation in patients with LTDFUs.


Asunto(s)
Diabetes Mellitus , Pie Diabético , Microbiota , Humanos , Pie Diabético/cirugía , Estudios Prospectivos , Estudios Retrospectivos , Amputación Quirúrgica , Adyuvantes Inmunológicos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda